Strategic partnership between Genedata and SCIEX deepens and accelerates characterization of next generation biotherapeutics

The collaboration will drive the development of new software solutions for in-depth characterization of novel biotherapeutics during the drug development process. July 29, 2021 Framingham, MA, USA and Basel, Switzerland — SCIEX, a global leader in life science analytical technologies, and Genedata, leading provider of biopharma enterprise software solutions, have entered into a strategic partnership to develop new software... Read more

Pacific Biosciences and Invitae Announce Intent to Expand Collaboration

Collaboration to develop production-scale HiFi Sequencing platformexpected to Include technology from Omniome, Inc. Combining both highly accurate long and short read sequencing technologies expected to provide deeper clinical insights and lower the overall cost of analysis MENLO PARK, Calif., July 20, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”),... Read more

Pacific Biosciences Signs Definitive Agreement to Acquire Omniome

Combination aims to transform the genomics landscape and deliver a differentiated product offering into high growth clinical markets Brings together Omniome’s high accuracy short-read sequencing platform, with PacBio’s market leading, high accuracy long-read solutions Transaction supported by concurrent $300 million PIPE financing from premier life science investors MENLO PARK, Calif. and SAN DIEGO, July 20,... Read more

Thermo Fisher Scientific Announces Collaboration with Ortho Clinical Diagnostics

Exclusive agreement to provide Thermo Scientific MAS Quality Controls for VITROS Analyzers FREMONT, Calif., July 7, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Ortho Clinical Diagnostics to promote and distribute Thermo Scientific MAS Quality Controls and LabLink xL Quality Assurance Software for use with Ortho Clinical Diagnostics VITROS... Read more

GE Healthcare partners with the Ministry of Health of the Democratic Republic of Congo to help efforts to fight COVID-19

June 30, 2021 – Kinshasa, Democratic Republic of Congo. GE Healthcare announces a partnership with the Ministry of Health of the Democratic Republic of Congo to deliver mobile X-ray units and ECG machines to help efforts to fight COVID-19. The essential medical equipment will play an important role in supporting the diagnosis and the management... Read more

Cytiva acquires Intermountain Life Sciences; will double capacity for buffers and liquid cell culture media

Combined with Cytiva’s existing manufacturing in Logan, Utah, Intermountain will boost global production of buffers and liquid cell culture media to Cytiva’s customers Responds to increased demand for products that are used in emerging modalities such as gene therapy, and are currently in high demand for the manufacture of COVID-19 vaccines and therapies Cytiva intends... Read more

Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute

06/28/21 Project Explores LC-MS Data Analytics Methods to Rapidly Characterize Complex Biomolecules NEWS SUMMARY: Waters expands collaboration with Bioprocessing Technology Institute, A*STAR into new areas meant to accelerate bioprocessing and bioinformatics research. Projects include developing analytical workflows for nucleic acid therapeutic products and bioinformatics research to deliver robust and accurate identification for a variety of... Read more

Pacific Biosciences and Rady Children’s Institute for Genomic Medicine Announce its First Research Collaboration for Whole Genome Sequencing

MENLO PARK, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, and Rady Children’s Institute for Genomic Medicine (RCIGM), a mission-driven, non-profit seeking to save lives and improve outcomes for patients, clinicians and families, shared today that they are... Read more

Tecan expands its commercial reach, its capabilities and its US and Asia presence with the acquisition of Paramit Corporation

Tecan to acquire Paramit Corporation, a leading OEM developer and manufacturer of medical devices and life sciences instruments, for a total consideration of USD 1.0 billion (CHF 920 million)  In full year 2021, Paramit is expected to generate around USD 280m in sales (CHF 257m) and around USD 50m EBITDA (CHF 46m), before acquisition-related costs  Transaction expected to be immediately and significantly accretive to earnings per share (EPS) upon closing  Adds complementary expertise, broadens design, development and manufacturing capabilities Expansion into the attractive and fast-growing medical... Read more